Ieq Capital LLC Acquires 1,587 Shares of Doximity, Inc. (NASDAQ:DOCS)

Ieq Capital LLC raised its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 3.0% during the 4th quarter, Holdings Channel.com reports. The fund owned 54,893 shares of the company’s stock after purchasing an additional 1,587 shares during the quarter. Ieq Capital LLC’s holdings in Doximity were worth $2,931,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in the stock. UMB Bank n.a. raised its holdings in shares of Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after purchasing an additional 235 shares during the last quarter. GAMMA Investing LLC grew its position in Doximity by 20.6% in the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company’s stock worth $93,000 after purchasing an additional 296 shares during the period. MetLife Investment Management LLC raised its stake in Doximity by 0.6% during the 3rd quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock valued at $2,835,000 after buying an additional 363 shares during the last quarter. State of Alaska Department of Revenue lifted its holdings in shares of Doximity by 2.6% during the 4th quarter. State of Alaska Department of Revenue now owns 14,610 shares of the company’s stock valued at $780,000 after buying an additional 370 shares during the period. Finally, First Horizon Advisors Inc. boosted its stake in shares of Doximity by 22.5% in the 3rd quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock worth $91,000 after buying an additional 384 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently commented on DOCS shares. Morgan Stanley upgraded Doximity from an “underweight” rating to an “equal weight” rating and upped their price objective for the company from $33.00 to $53.00 in a research report on Thursday, November 14th. Canaccord Genuity Group cut shares of Doximity from a “buy” rating to a “hold” rating and increased their price objective for the stock from $40.00 to $60.00 in a research note on Wednesday, November 13th. Mizuho boosted their target price on shares of Doximity from $55.00 to $65.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Wells Fargo & Company reaffirmed an “equal weight” rating on shares of Doximity in a report on Friday, February 7th. Finally, KeyCorp dropped their price target on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 8th. Eleven investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $64.22.

Insider Buying and Selling at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the transaction, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 37.40% of the company’s stock.

Doximity Trading Down 3.7 %

Shares of DOCS opened at $72.25 on Friday. The business’s 50 day moving average is $60.19 and its 200 day moving average is $49.21. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21. The company has a market capitalization of $13.49 billion, a PE ratio of 72.25, a price-to-earnings-growth ratio of 4.10 and a beta of 1.39.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.